Beta Drugs Limited — Important, 22-09-2025: Updates
22-09-2025 | 09:15 am
22-09-2025 | 09:15 am
Beta Drugs received INVIMA-Colombia approval for its injectable and oral oncology formulations, opening significant growth avenues in Latin America's third-largest pharma market. This, coupled with EAEU approval, strengthens its global presence in the rapidly expanding oncology market.
No comments yet. Be the first to comment!
